Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127384942 | 12738494 | 2 | F | 201608 | 20160912 | 20160913 | 20160916 | PER | US-PFIZER INC-2016428945 | PFIZER | 64.00 | YR | F | Y | 72.57000 | KG | 20160916 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127384942 | 12738494 | 1 | PS | TOVIAZ | FESOTERODINE FUMARATE | 1 | 8 MG, 1X/DAY | N88335 | 22030 | 8 | MG | MODIFIED-RELEASE TABLET | QD | ||||||
127384942 | 12738494 | 2 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | 1.25 MG, 1X/DAY | 0 | 1.25 | MG | QD |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127384942 | 12738494 | 1 | Hypertonic bladder |
127384942 | 12738494 | 2 | Hypothyroidism |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127384942 | 12738494 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
127384942 | 12738494 | 1 | 2011 | 0 |